BAFF receptor antibody for mantle cell lymphoma therapy

Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin’s lymphoma and remains incurable under current treatment modalities. One of the main reasons for treatment failure is the development of drug resistance. Accumulating evidence suggests that B cell activating factor (BAFF) and BAF...

Full description

Saved in:
Bibliographic Details
Published in:Oncoimmunology
Main Authors: Zhang, Keman, Roy, Nand K, Vicioso, Yorleny, Woo, Janghee, Beck, Rose, de Lima, Marcos, Caimi, Paolo, Feinberg, Daniel, Parameswaran, Reshmi
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2021
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7939563/
https://ncbi.nlm.nih.gov/pubmed/33747637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1893501
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items